India Pharma
- All
- News
- Videos
- Web Stories
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
